Search Results for agency_names:"Justice Department"

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Dr. Kim Routh from Grove City, Ohio, because he lost his medical license in Ohio, rendering him unable to legally handle controlled substances. The revocation is based on an Order to Show Cause issued by the DEA, which Dr. Routh did not contest by requesting a hearing. The document states that having a valid state medical license is a crucial requirement for holding a DEA registration, and without it, Dr. Routh cannot continue to administer or prescribe controlled substances. The order also denies any pending applications from Dr. Routh to renew or modify his registration.

The Department of Justice has lodged a proposed Consent Decree concerning a case where the United States accused Thomas E. Lipar and associated companies of violating the Clean Water Act by discharging pollutants without a permit. To settle these allegations, the defendants are required to perform compensatory environmental mitigation and adhere to best management practices. The public had initially been given until February 25, 2021, to comment on this proposed agreement, but the deadline was extended to March 11, 2021. The details of the Consent Decree can be reviewed online or at the United States District Court for the Southern District of Texas, although access may be restricted due to COVID-19.

The Drug Enforcement Administration (DEA) sought to revoke two registrations of Jason Weakley, a registered nurse and advanced practice registered nurse, because he was not authorized to handle controlled substances in Vermont and New Hampshire. Weakley's nursing licenses in both states had expired and remained suspended. He was informed of his right to a hearing but did not request one, leading to a default judgment against him. Consequently, the DEA revoked his registrations, preventing him from handling controlled substances and from renewing or applying for new registrations in these states.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause and Immediate Suspension of Registrations to Empire Pharmacy and Skyline Pharmacy in Philadelphia, claiming their activities posed an imminent danger to public health. Between 2019 and 2023, the pharmacies failed to maintain accurate records of controlled substances, violating federal and state laws. When the pharmacies did not request a hearing to dispute these claims, the DEA moved forward with final actions to revoke their registrations. Due to their failure to comply and their inadequate responses, the DEA decided to revoke both pharmacies' DEA Certificates of Registration.

The Drug Enforcement Administration (DEA) has announced that Royal Beverages, LLC has applied to become a registered bulk manufacturer of marijuana, which is a Schedule I controlled substance. This registration would allow Royal Beverages, LLC, located in Harrisburg, Pennsylvania, to produce bulk active pharmaceutical ingredients (APIs) for research purposes. Comments or objections about this application can be submitted electronically through the Federal eRulemaking Portal before May 27, 2025. The DEA will evaluate the application based on certain legal regulations to ensure it complies with all laws and safeguards against illegal distribution.

The Department of Justice, specifically the Drug Enforcement Administration (DEA), is requesting public feedback on a proposed information collection related to emergency medical services and controlled substances. This proposal aims to ensure compliance with the Controlled Substances Act by setting new recordkeeping standards for emergency medical services agencies. These standards involve maintaining records of controlled substances used by these agencies, which include details about administration, disposal, and delivery. The DEA encourages comments on the necessity, burden, and clarity of this information collection until January 13, 2025, as part of their efforts to secure approval for a three-year authorization under the Paperwork Reduction Act.

The Drug Enforcement Administration (DEA) has announced that Sterling Wisconsin, LLC applied to register as a bulk manufacturer of certain controlled substances, specifically synthetic versions of Marihuana Extract, Marihuana, and Tetrahydrocannabinols. Interested parties can submit comments or objections electronically or request a hearing until May 27, 2025. The application was filed on January 30, 2025, and comments should be submitted via the Federal eRulemaking Portal as instructed.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Laura M. Bellew, a nurse practitioner from New Mexico, proposing to revoke her DEA registration because she no longer has the authority to handle controlled substances in New Mexico. This is because her nursing licenses were suspended by the New Mexico State Board of Nursing in January 2023. Bellew did not request a hearing to contest the charges, effectively admitting the DEA's allegations. As a result, the DEA decided to revoke her registration and deny any pending applications related to controlled substances in New Mexico.

The Blockchain Security Standards Council, Inc. (BSSC) has informed the Attorney General and the Federal Trade Commission about changes in its membership as part of a notice filed under the National Cooperative Research and Production Act of 1993. Specifically, Turnkey Global, Inc. and BitGo have joined the venture. This notice aims to provide antitrust protection for group members under certain conditions. Membership in the project remains open, and BSSC plans to continue reporting any changes.

The Department of Justice has lodged a proposed Consent Decree with the court to settle claims against American Zinc Recycling Corp. for environmental law violations at their facility in Palmerton, Pennsylvania. These claims involve federal laws such as the Clean Air Act, Resource Conservation and Recovery Act, Clean Water Act, and Emergency Planning and Community Right-to-Know Act, along with several Pennsylvania state laws. Under the Consent Decree, the company must implement new pollution control measures and pay a $3.3 million penalty, split between the U.S. and Pennsylvania. There is a public comment period on the Consent Decree, during which the document can be reviewed online or requested by mail.